CAS 29218-27-7|Toloxatone
Introduction：Basic information about CAS 29218-27-7|Toloxatone, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Toloxatone | ||
|---|---|---|---|
| CAS Number | 29218-27-7 | Molecular Weight | 207.23 |
| Density | 1.245g/cm3 | Boiling Point | 358.9ºC at 760mmHg |
| Molecular Formula | C11H13NO3 | Melting Point | 76° |
| MSDS | ChineseUSA | Flash Point | 170.9ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 2-oxazolidinone, 5-(hydroxymethyl)-3-(3-methylphenyl) |
|---|---|
| Synonym | More Synonyms |
Toloxatone BiologicalActivity
| Description | Toloxatone (MD 69276) is a reversible monoamine oxidase A (MAOA) inhibitor[1]. Antidepressant[1]. |
|---|---|
| Related Catalog | Signaling Pathways >>Neuronal Signaling >>Monoamine OxidaseResearch Areas >>Neurological Disease |
| Target | MAOA[1] |
| References | [1]. FMoureau, et al. A reversible monoamine oxidase inhibitor, toloxatone: spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD). European Journal of Medicinal Chemistry. 1994, 29(4):269-277. |
Chemical & Physical Properties
| Density | 1.245g/cm3 |
|---|---|
| Boiling Point | 358.9ºC at 760mmHg |
| Melting Point | 76° |
| Molecular Formula | C11H13NO3 |
| Molecular Weight | 207.23 |
| Flash Point | 170.9ºC |
| Exact Mass | 207.09000 |
| PSA | 49.77000 |
| LogP | 1.37750 |
| Vapour Pressure | 8.9E-06mmHg at 25°C |
| Index of Refraction | 1.57 |
| InChIKey | MXUNKHLAEDCYJL-UHFFFAOYSA-N |
| SMILES | Cc1cccc(N2CC(CO)OC2=O)c1 |
| Storage condition | 2-8°C |
| Water Solubility | DMSO: >10mg/mL |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1225 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1300 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 650 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| RIDADR | UN 3249 |
| RTECS | RQ2867500 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2934999090 |
Customs
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles26
More Articles| 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug Test. Anal. 6(7-8) , 607-13, (2014) 5-(2-Aminopropyl)indole (5-IT) is a psychoactive compound that has recently been associated with several fatal and non-fatal intoxications in a number of European countries. There are indications that... | |
| Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells. J. Pharmacol. Exp. Ther. 356 , 483-92, (2016) According to the catecholaldehyde hypothesis, the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) contributes to the loss of nigrostriatal dopaminergic neurons in Parkinson's disease... | |
| A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder. Psychopharmacology 106 Suppl , S118-9, (1992) A double-blind comparison of moclobemide and toloxatone was performed in adult out-patients diagnosed as suffering from a major depressive disorder. Parallel groups of patients received moclobemide, 4... |
Synonyms
| 5-(hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone Humoryl |
| Toloxatone |
| 5-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one |
| 5-hydroxymethyl-3-(3-methylphenyl)-2-oxazolidinone |
| ToloxatonetoloxatonetoloxatoneToloxatone |
| Perenum |
| EINECS 249-522-2 |
| MFCD00865391 |
| Humoryl |
| 5-(hydroxymethyl)-3-m-tolyl-2-oxazolidinone |
| 5-Hydroxymethyl-3-(3-methylphenyl)oxazolidin-2-one |
